- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Rheumatoid arthritis;Juvenile idiopathic arthritis;Psoriatic arthritis;Plaque psoriasis;Ankylosing spondylitis.
- Meeting Date: November 2022
- Public Summary Document (PSD) November 2022 PBAC Meeting - (PDF 335KB)
- Public Summary Document (PSD) November 2022 PBAC Meeting - (Word 52KB)
Etanercept – November 2022
Etanercept: Injection 50 mg in 1 mL single use auto-injector, 4; Nepexto®
Last updated
3 March 2023